Concentras Parent PE Ratio 2025-2024 | CON
Current and historical p/e ratio for Concentras Parent (CON) from 2025 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Concentras Parent PE ratio as of September 17, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Concentras Parent PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-09-17 | 23.21 | inf |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $2.956B | $1.838B |
Concentra Group Holdings Parent Inc. is a provider of occupational health services principally in the United States. Concentra Group Holdings Parent Inc. is based in MECHANICSBURG, Pa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $128.349B | 15.65 |
Cencora (COR) | United States | $47.536B | 18.17 |
ICON (ICLR) | Ireland | $24.384B | 21.91 |
DiDi Global (DIDIY) | China | $18.907B | 0.00 |
Avantor (AVTR) | United States | $18.492B | 28.04 |
Natera (NTRA) | United States | $16.038B | 0.00 |
Revvity (RVTY) | United States | $15.146B | 26.52 |
Viatris (VTRS) | United States | $14.095B | 4.29 |
CochLear (CHEOY) | Australia | $12.834B | 0.00 |
Solventum (SOLV) | United States | $12.399B | 0.00 |
Medpace Holdings (MEDP) | United States | $11.058B | 33.56 |
Charles River Laboratories (CRL) | United States | $10.519B | 19.88 |
Sonic Healthcare (SKHHY) | Australia | $8.839B | 0.00 |
Doximity (DOCS) | United States | $7.322B | 46.40 |
HealthEquity (HQY) | United States | $6.833B | 37.08 |
Bausch + Lomb (BLCO) | Canada | $6.266B | 26.97 |
PACS (PACS) | United States | $6.244B | 0.00 |
Organon (OGN) | United States | $5.376B | 5.47 |
Life Times (LTH) | United States | $4.877B | 40.77 |
Sotera Health (SHC) | United States | $4.789B | 24.16 |
Surgery Partners (SGRY) | United States | $4.050B | 44.87 |
GoodRx Holdings (GDRX) | United States | $2.914B | 109.71 |
Ardent Health Partners (ARDT) | United States | $2.506B | 0.00 |
BrightSpring Health Services (BTSG) | United States | $2.387B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.202B | 0.00 |
Progyny (PGNY) | United States | $2.195B | 38.59 |
Premier (PINC) | United States | $2.080B | 9.35 |
Ryman Healthcare (RYHTY) | New Zealand | $2.023B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.751B | 8.79 |
CareDx (CDNA) | United States | $1.568B | 0.00 |
Teladoc Health (TDOC) | United States | $1.397B | 0.00 |
Agilon Health (AGL) | United States | $1.350B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
GeneDx Holdings (WGS) | United States | $1.016B | 0.00 |
Embecta (EMBC) | United States | $0.950B | 6.33 |
QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
Pediatrix Medical (MD) | United States | $0.923B | 10.05 |
InnovAge Holding (INNV) | United States | $0.802B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.537B | 0.00 |
Sharecare (SHCR) | United States | $0.521B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.492B | 0.00 |
Enhabit (EHAB) | United States | $0.405B | 35.00 |
Sonida Senior Living (SNDA) | United States | $0.373B | 0.00 |
DocGo (DCGO) | United States | $0.372B | 14.00 |
Biodesix (BDSX) | United States | $0.260B | 0.00 |
Sera Prognostics (SERA) | United States | $0.258B | 0.00 |
LifeMD (LFMD) | United States | $0.221B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.204B | 0.00 |
Beauty Health (SKIN) | United States | $0.185B | 0.00 |
ModivCare (MODV) | United States | $0.181B | 5.76 |
MultiPlan (MPLN) | United States | $0.153B | 0.00 |
Nutex Health (NUTX) | United States | $0.127B | 0.00 |
So-Young (SY) | China | $0.083B | 20.00 |
Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.082B | 0.00 |
Pono Capital Two (PTWO) | United States | $0.057B | 0.00 |
NeueHealth (NEUE) | United States | $0.042B | 1.69 |
OncoCyte (OCX) | United States | $0.042B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.032B | 0.00 |
Pheton Holdings (PTHL) | China | $0.030B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.025B | 0.00 |
Oncology Institute (TOI) | United States | $0.023B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.020B | 0.00 |
TRxADE HEALTH (MEDS) | United States | $0.011B | 0.00 |
XWELL (XWEL) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
KindlyMD (KDLY) | $0.008B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |